Extracted from this filing and checked against the source text.
Earnings Releases
SEC 8-K Item 2.02
confidence 0.9
GLOBUS MEDICAL INC reported the fourth quarter ended December 31, 2023 results: revenue $ 616.5 million, net income $ 15.0 million, EPS $0.11.
- Period
- the fourth quarter ended December 31, 2023
- Revenue
- $ 616.5 million
- Net income
- $ 15.0 million
- EPS
- $0.11
- Result
- reported results
Exact text from the filing
Worldwide net sales for the fourth quarter were $ 616.5 million
View on SEC.gov
Earnings Releases
SEC 8-K Item 2.02
confidence 0.9
GLOBUS MEDICAL INC reported the fiscal year ended December 31, 2023 results: revenue $ 1,568.5 million, net income $ 122.9 million, EPS $1.07. Guidance reaffirmed.
- Period
- the fiscal year ended December 31, 2023
- Revenue
- $ 1,568.5 million
- Net income
- $ 122.9 million
- EPS
- $1.07
- Guidance
- reaffirmed
- Result
- reported results
Exact text from the filing
EPS ”) was $0. 11 and non-GAAP diluted EPS was $0. 60 · Non-GAAP adjusted EBITDA was $ 1 70.0 million, or 27. 6 % of net sales Full Year 20 2 3 : · Worldwide net sales were $ 1,568.5 million , an increase of 53.3% on an actual and constant currency basis · GAAP n et income for the year was $ 122.9 million · GAAP d iluted EPS was $ 1.07 and n on-GAAP diluted EPS was $
View on SEC.gov